Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Description
Solid cancer patients are at higher risk of SARS-CoV-2 infection and severe complications. Moreover, vaccine-induced antibody response is impaired in patients on anticancer treatment. In this retrospective, observational, hypothesis-generating
